BACKGROUND: Obesity has been associated with a chronic low degree inflammatory response, characterized by an increase of inflammatory adipocytokines like tumoral necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) as well as the synthesis of acute phase reactants such as haptoglobin. AIM OF THE STUDY: To evaluate if impairments in the inflammatory response at the white adipose tissue (WAT) level could be involved in the mechanisms conferring susceptibility or resistance to high-fat diet-induced obesity (DIO). METHODS: The expression levels of WAT genes and systemic markers related to inflammation were evaluated in two groups of rats fed with a high-fat diet during 15 days that showed either an early susceptibility (DIO) or resistance (DR) to develop obesity. We also tested the efficacy of the eicosapentaenoic (EPA) omega-3 fatty acid treatment (35 days) to potentially counteract the obesity-associated inflammatory features in DIO rats. RESULTS: This trial showed that high-fat diet induces an increase on mRNA levels on TNF-alpha and haptoglobin in DIO animals (P < 0.05), while no significant changes were observed on DR rats. Furthermore, a significant increase in IL-6 mRNA (P < 0.05) was found in both DR and DIO rats. EPA-treatment caused a significant decrease in IL-6 mRNA (P < 0.05), without significant changes in haptoglobin mRNA levels in adipose tissue. An unexpected decrease was observed in haptoglobin serum levels (P < 0.05) in DIO rats, which was reverted to control values in EPA-treated animals. CONCLUSIONS: Our data suggest that obesity susceptibility or resistance may depend on the genetic make up related to inflammatory features, and support a role for omega-3 fatty acids in the prevention of obesity-associated inflammation in adipose tissue. In addition, our data do not support the hypothesis that serum haptoglobin is an acute phase protein expected to be positively related to increased adiposity in rats, at least in early and medium stages of DIO.
BACKGROUND:Obesity has been associated with a chronic low degree inflammatory response, characterized by an increase of inflammatory adipocytokines like tumoral necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6) as well as the synthesis of acute phase reactants such as haptoglobin. AIM OF THE STUDY: To evaluate if impairments in the inflammatory response at the white adipose tissue (WAT) level could be involved in the mechanisms conferring susceptibility or resistance to high-fat diet-induced obesity (DIO). METHODS: The expression levels of WAT genes and systemic markers related to inflammation were evaluated in two groups of rats fed with a high-fat diet during 15 days that showed either an early susceptibility (DIO) or resistance (DR) to develop obesity. We also tested the efficacy of the eicosapentaenoic (EPA) omega-3 fatty acid treatment (35 days) to potentially counteract the obesity-associated inflammatory features in DIO rats. RESULTS: This trial showed that high-fat diet induces an increase on mRNA levels on TNF-alpha and haptoglobin in DIO animals (P < 0.05), while no significant changes were observed on DR rats. Furthermore, a significant increase in IL-6 mRNA (P < 0.05) was found in both DR and DIO rats. EPA-treatment caused a significant decrease in IL-6 mRNA (P < 0.05), without significant changes in haptoglobin mRNA levels in adipose tissue. An unexpected decrease was observed in haptoglobin serum levels (P < 0.05) in DIO rats, which was reverted to control values in EPA-treated animals. CONCLUSIONS: Our data suggest that obesity susceptibility or resistance may depend on the genetic make up related to inflammatory features, and support a role for omega-3 fatty acids in the prevention of obesity-associated inflammation in adipose tissue. In addition, our data do not support the hypothesis that serum haptoglobin is an acute phase protein expected to be positively related to increased adiposity in rats, at least in early and medium stages of DIO.
Authors: C Chiellini; F Santini; A Marsili; P Berti; A Bertacca; C Pelosini; G Scartabelli; E Pardini; J López-Soriano; R Centoni; A M Ciccarone; L Benzi; P Vitti; S Del Prato; A Pinchera; M Maffei Journal: J Clin Endocrinol Metab Date: 2004-06 Impact factor: 5.958
Authors: Silvia Lorente-Cebrián; André G V Costa; Santiago Navas-Carretero; María Zabala; J Alfredo Martínez; María J Moreno-Aliaga Journal: J Physiol Biochem Date: 2013-06-22 Impact factor: 4.158
Authors: Anita R Alvheim; Bente E Torstensen; Yu Hong Lin; Haldis H Lillefosse; Erik-Jan Lock; Lise Madsen; Joseph R Hibbeln; Marian K Malde Journal: Br J Nutr Date: 2012-08-10 Impact factor: 3.718